Beta
296228

Therapeutic Effect of Quercetin in Letrozole Induced Polycystic Ovary Syndrome in Rat Model

Article

Last updated: 01 Jan 2025

Subjects

-

Tags

-

Abstract

Abstract Background: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders diagnosed in women. The prevalence of polycystic ovary syndrome is estimated to be between 2.2% and 26% among women. Inflammation is thought to play a role in the pathogenesis of PCOS. Quercetin is a flavonoid that has been shown to be anti-inflammatory and antioxidant so, the aim of this study was to differentiate between the effects of two doses of quercetin & to provide natural, safe, and effective treatment of polycystic ovary syndrome. Aim of Study: The aim of the present study was to deter-mine the role of quercetin in treatment of Letrozole Induced polycystic ovary syndrome in rat model and determine the effects of two different doses of quercetin. Material and Methods: Adult nonobese female rats were induced to polycystic ovary syndrome by using 1mg/kg of letrozole and confirmed to be diseased by vaginal smears. A group of the experimental rats received 50mg/kg of quercetin; another group received 100mg/kg of quercetin & another one received 100mg/kg of metformin. LH, FSH, (LH/FSH) ratio, hormonal profile, catalase, TNF-a, serum glucose level, insulin sensitivity and ovarian morphology by hematoxylin & eosin (H&E), Masson trichrome (MTC), periodic acid-Schiff (PAS) & anti transforming growth factor beta (TGF-P) stains were then assessed in addition to the weight of the rats and their temperature after induction and after treatment. Results: Treatment with quercetin significantly decreased testosterone & TNF-a and increased FSH, LH, estrogen, progesterone & catalase. It decreased body weight & body hair distribution. It also improved insulin sensitivity & im-proved histological structure of the ovary. 100mg/kg of quercetin had better results than the dose of 50mg/kg of quercetin & metformin in the parameters we measured. 50mg/kg of quercetin & metformin were comparable in their results.

DOI

10.21608/mjcu.2022.296228

Keywords

polycystic ovary syndrome, Quercetin, Letrozole

Authors

First Name

FATEN ABBAS MOHAMED, M.D.*

Last Name

OMNIA E. MAAMOUN, M.B.B.Ch.*; SALLY M. ABDELMONEM, M.D.*; CHRISTINA S. EISSA, M.D.**

MiddleName

-

Affiliation

The Departments of Physiology* and Histology & Cell Biology**, Faculty of Medicine, Suez Canal University

Email

-

City

-

Orcid

-

Volume

90

Article Issue

12

Related Issue

39806

Issue Date

2022-12-01

Receive Date

2023-04-23

Publish Date

2022-12-01

Page Start

2,777

Page End

2,799

Print ISSN

0045-3803

Online ISSN

2536-9806

Link

https://mjcu.journals.ekb.eg/article_296228.html

Detail API

https://mjcu.journals.ekb.eg/service?article_code=296228

Order

296,228

Type

Original Article

Type Code

263

Publication Type

Journal

Publication Title

The Medical Journal of Cairo University

Publication Link

https://mjcu.journals.ekb.eg/

MainTitle

Therapeutic Effect of Quercetin in Letrozole Induced Polycystic Ovary Syndrome in Rat Model

Details

Type

Article

Created At

30 Dec 2024